Anti-inflammatory therapy in the prevention of cardiovascular disease

November 2017

Publication: Physicians' Academy for Cardiovascular Education

Source / Author: Professor Peter Libby & Physicians' Academy for Cardiovascular Education

Prof. Libby discusses IL-1β as a target for atherosclerosis therapy, a strategy that was evaluated in the CANTOS trial, which tested the monoclonal antibody canakinumab.

View here

September 2023

Author: Caristo Sponsored Symposium

Caristo at SCCT 2023 – Raising the bar for coronary artery disease management

The Caristo team were delighted to meet with the CCTA community at the Society of Cardiovascular Computed Tomography (SCCT) Annual…

Cover photo for Caristo's Symposium at SCCT Symposium

February 2023

Author: Caristo Sponsored Symposium

The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…